Charles Levenback, MD is Professor and Deputy Chairman, Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA, and formerly Chief Professionalism Officer. In 2017 he shared the Society of Gynecologic Oncology Innovation Award in recognition for his role in the development of sentinel lymph node biopsy in gynecologic oncology patients and his lead investigator role in multiple institutional and national clinical trials.Ate G.J. van der Zee, MD, PhD is Professor of Gynaecological Oncology and Vice President of the Board of Directors, University Medical Center Groningen, The Netherlands. He leads a world-wide consortium (GROINSS-V-II), which performs landmark clinical studies in vulvar cancer, and shared the SGO Innovation Award in 2017. Robert L. Coleman, MD, FACOG, FACS is Chief Scientific Officer, US Oncology Research, The US Oncology Network, McKesson Specialty Health, The Woodlands, TX, USA, and formerly Professor and Ann Rife Cox Chair of the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas MD Anderson Cancer Center and Executive Director of Cancer Network Research.
